NO763372L - - Google Patents

Info

Publication number
NO763372L
NO763372L NO763372A NO763372A NO763372L NO 763372 L NO763372 L NO 763372L NO 763372 A NO763372 A NO 763372A NO 763372 A NO763372 A NO 763372A NO 763372 L NO763372 L NO 763372L
Authority
NO
Norway
Application number
NO763372A
Other languages
Norwegian (no)
Other versions
NO143219C (no
NO143219B (no
Inventor
L Lafon
Original Assignee
Lafon Labor
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lafon Labor filed Critical Lafon Labor
Publication of NO763372L publication Critical patent/NO763372L/no
Publication of NO143219B publication Critical patent/NO143219B/no
Publication of NO143219C publication Critical patent/NO143219C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00Sulfones; Sulfoxides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/20Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
NO763372A 1975-10-02 1976-10-01 Analogifremgangsmaate for fremstilling av terapeutisk aktive forbindelser. NO143219C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB40419/75A GB1520812A (en) 1975-10-02 1975-10-02 Benzhydrylsulphinyl derivatives

Publications (3)

Publication Number Publication Date
NO763372L true NO763372L (ja) 1977-04-05
NO143219B NO143219B (no) 1980-09-22
NO143219C NO143219C (no) 1981-01-07

Family

ID=10414819

Family Applications (1)

Application Number Title Priority Date Filing Date
NO763372A NO143219C (no) 1975-10-02 1976-10-01 Analogifremgangsmaate for fremstilling av terapeutisk aktive forbindelser.

Country Status (29)

Country Link
US (1) US4066686A (ja)
JP (1) JPS6045186B2 (ja)
AT (1) AT347426B (ja)
AU (1) AU511619B2 (ja)
BE (1) BE846880A (ja)
CH (1) CH614934A5 (ja)
CS (1) CS200195B2 (ja)
DE (1) DE2642511C2 (ja)
DK (1) DK151009C (ja)
ES (1) ES452063A1 (ja)
FI (1) FI63220C (ja)
FR (1) FR2326181A1 (ja)
GB (1) GB1520812A (ja)
GE (1) GEP19960242B (ja)
HU (1) HU175109B (ja)
IE (1) IE43553B1 (ja)
IL (1) IL50599A (ja)
LU (1) LU75909A1 (ja)
NL (1) NL187629C (ja)
NO (1) NO143219C (ja)
NZ (1) NZ182207A (ja)
OA (1) OA05444A (ja)
PH (1) PH12533A (ja)
PL (1) PL105506B1 (ja)
PT (1) PT65648B (ja)
SE (1) SE431088B (ja)
SU (1) SU651693A3 (ja)
YU (1) YU40464B (ja)
ZA (1) ZA765830B (ja)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1106403A (en) * 1977-04-29 1981-08-04 Victor Lafon Process for preparing (3,4-dichlorophenyl-sulphinyl)- acetamidoxime and its addition salts
FR2528041A1 (fr) * 1982-06-04 1983-12-09 Lafon Labor Acides halogenobenzhydrylsulfinylacetohydroxamiques, procede de preparation et utilisation en therapeutique
FR2528040A1 (fr) * 1982-06-04 1983-12-09 Lafon Labor Benzhydrylsulfinylethylamines, procede de preparation et utilisation en therapeutique
GB8320943D0 (en) * 1983-08-03 1983-09-07 Lilly Industries Ltd Organic compounds
FR2561646B1 (fr) * 1984-03-23 1987-10-09 Lafon Labor Derives d'acide (a-(alkylaminomethyl)-benzyl)-thioacetique, procede de preparation et utilisation en therapeutique
FR2569186B1 (fr) * 1984-08-20 1986-09-05 Lafon Labor Derives de 1-(n-(a-amino-a-methylacetyl)-aminophenyl)-2-amino-propanone, procede de preparation et utilisation en therapeutique
DE3604050A1 (de) * 1986-02-08 1987-08-13 Boehringer Mannheim Gmbh Thioether, verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel
FR2606015B1 (fr) * 1986-08-13 1989-05-19 Lafon Labor Derives du benzhydrylthiomethane, leurs procedes de preparation et leurs applications en therapeutique
JPH02162176A (ja) * 1988-12-14 1990-06-21 Sanyo Electric Co Ltd ライトの取付装置
FR2663225B1 (fr) * 1990-06-14 1994-11-04 Lafon Labor Nouvelle utilisation du modafinil.
FR2708201B1 (fr) * 1993-06-30 1995-10-20 Lafon Labor Utilisation de dérivés d'acétamide pour la fabrication de médicaments.
US5571825A (en) * 1995-03-31 1996-11-05 Warner-Lambert Company Method of selectively inhibiting prostaglandin G/H synthase-2
US6172057B1 (en) 1997-02-27 2001-01-09 American Cyanamid Company N-Hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
KR20000075808A (ko) * 1997-02-27 2000-12-26 윌리암 에이취 캘넌, 에곤 이 버그 매트릭스 메탈로프로테이나제 억제제로서의 n-하이드록시-2-(알킬, 아릴, 또는 헤테로아릴 설파닐, 설피닐 또는 설포닐)-3-치환된 알킬, 아릴 또는 헤테로아릴아미드
US6670358B2 (en) * 2000-05-16 2003-12-30 Cephalon, Inc. Substituted thioacetamides
US6492396B2 (en) * 2000-05-16 2002-12-10 Cephalon, Inc. Substituted thioacetamides
US6875893B2 (en) * 2002-05-23 2005-04-05 Cephalon, Inc. Preparations of a sulfinyl acetamide
US6992219B2 (en) * 2002-08-09 2006-01-31 Cephalon France Modafinil polymorphic forms
EP1437345A1 (en) * 2003-01-13 2004-07-14 Organisation de Synthese Mondiale Orsymonde Novel method for preparing methyl 2-diphenylmethylsulfinylacetate
WO2004075827A2 (en) * 2003-01-31 2004-09-10 Alembic Limited Process for the preparation of 2-[(diphenylmethyl) thio] acetamide
MXPA05008088A (es) * 2003-02-24 2005-09-21 Mallinckrodt Inc Proceso mejorado para preparar benzhidril tioacetamida.
ITMI20031298A1 (it) * 2003-06-26 2004-12-27 Erregierre Spa Processo di preparazione di modafinil forma polimorfa(i).
WO2005046854A2 (en) * 2003-09-12 2005-05-26 Sun Pharmaceutical Industries Limited A process for the preparation of diphenylmethylsulfinyl derivatives
US7314875B2 (en) * 2004-04-13 2008-01-01 Cephalon, Inc. Tricyclic aromatic and bis-phenyl sulfinyl derivatives
EP1586560A1 (en) * 2004-04-13 2005-10-19 Cephalon, Inc. Thio-substituted arylmethanesulfinyl derivatives
US7297817B2 (en) * 2004-04-13 2007-11-20 Cephalon France Thio-substituted arylmethanesulfinyl derivatives
US7449481B2 (en) * 2004-04-13 2008-11-11 Cephalon, Inc. Thio-substituted biaryl-methanesulfinyl derivatives
US7119214B2 (en) * 2004-04-13 2006-10-10 Cephalon France Thio-substituted tricyclic and bicyclic aromatic methanesulfinyl derivatives
KR20090031618A (ko) * 2006-07-12 2009-03-26 엘란 코포레이션, 피엘씨 나노입자형 모다피닐 제제
US20100010092A1 (en) * 2006-12-19 2010-01-14 Arless Ltd. Use of modafinil to treat restless leg syndrome
USD681056S1 (en) * 2012-09-09 2013-04-30 Apple Inc. Electronic device
EP2964611B1 (en) 2013-03-08 2022-10-19 The United States of America, as represented by The Secretary, Department of Health and Human Services Potent and selective inhibitors of monoamine transporters; method of making; and use thereof
CN104610108B (zh) * 2015-01-27 2016-03-30 潍坊医学院 一种中枢神经系统药物阿屈非尼中间体化合物的合成方法
WO2019094856A1 (en) 2017-11-13 2019-05-16 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Atypical inhibitors of monoamine transporters; method of making; and use thereof
KR102126389B1 (ko) 2018-09-14 2020-06-25 셀라이온바이오메드 주식회사 벤즈히드릴티오 아세트아미드 화합물을 유효성분으로 포함하는 간 질환의 예방 또는 치료용 조성물
KR102277739B1 (ko) 2019-12-11 2021-07-15 셀라이온바이오메드 주식회사 벤즈히드릴 티오 아세트아미드 화합물을 유효성분으로 포함하는 섬유화 질환의 치료용 조성물

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2394597A (en) * 1942-07-09 1946-02-12 Eastman Kodak Co Preparation of organic dhsocyanates
NL6406688A (ja) * 1964-06-05 1965-12-06

Also Published As

Publication number Publication date
ATA720876A (de) 1978-05-15
CS200195B2 (cs) 1980-08-29
GB1520812A (en) 1978-08-09
FI762810A (ja) 1977-04-03
GEP19960242B (en) 1996-06-01
HU175109B (hu) 1980-05-28
SU651693A3 (ru) 1979-03-05
AU1818876A (en) 1978-04-06
NO143219C (no) 1981-01-07
DE2642511A1 (de) 1977-04-14
SE431088B (sv) 1984-01-16
IE43553L (en) 1977-04-02
ZA765830B (en) 1977-09-28
LU75909A1 (ja) 1977-05-11
AU511619B2 (en) 1980-08-28
NZ182207A (en) 1978-03-06
FR2326181A1 (fr) 1977-04-29
FI63220C (fi) 1983-05-10
PH12533A (en) 1979-05-17
JPS6045186B2 (ja) 1985-10-08
NL187629B (nl) 1991-07-01
NL7610929A (nl) 1977-04-05
ES452063A1 (es) 1977-10-01
BE846880A (fr) 1977-04-01
SE7610940L (sv) 1977-04-03
IL50599A0 (en) 1976-12-31
PL105506B1 (pl) 1979-10-31
DK151009C (da) 1988-02-29
PT65648B (fr) 1978-04-07
JPS5246058A (en) 1977-04-12
YU40464B (en) 1986-02-28
DE2642511C2 (de) 1986-07-31
AT347426B (de) 1978-12-27
DK151009B (da) 1987-10-12
YU241476A (en) 1982-02-28
IE43553B1 (en) 1981-03-25
DK437576A (da) 1977-04-03
PT65648A (pt) 1976-10-01
OA05444A (fr) 1981-03-31
NL187629C (nl) 1991-12-02
FI63220B (fi) 1983-01-31
US4066686A (en) 1978-01-03
IL50599A (en) 1980-09-16
CH614934A5 (ja) 1979-12-28
FR2326181B1 (ja) 1980-08-08
NO143219B (no) 1980-09-22

Similar Documents

Publication Publication Date Title
NO763372L (ja)
FR2299171B1 (ja)
FR2296623B1 (ja)
FR2323948B3 (ja)
JPS567597B2 (ja)
JPS51102107U (ja)
JPS51153952U (ja)
JPS51116198U (ja)
JPS5533725Y2 (ja)
JPS5435605Y2 (ja)
JPS5246523B2 (ja)
JPS5260529U (ja)
JPS5197094U (ja)
JPS5252217U (ja)
JPS5254324U (ja)
CS175206B1 (ja)
CH604671A5 (ja)
CH603151A5 (ja)
CH598520A5 (ja)
BG21547A1 (ja)
BG21537A1 (ja)
DD120063A1 (ja)
CH599916A5 (ja)
CH605297A5 (ja)
CH598404B5 (ja)